Manilith 450 SR Tablet
Rs.44.60for 1 strip(s) (10 tablet sr each)
Manilith Tablet SR માટે આંતરક્રિયાનો ખોરાક
Manilith Tablet SR માટે આંતરક્રિયાનો આલ્કોહોલ
Manilith Tablet SR માટે આંતરક્રિયાનો સગર્ભાવસ્થા
Manilith Tablet SR માટે આંતરક્રિયાનો સ્તનપાન
ખોરાક
આલ્કોહોલ
સગર્ભાવસ્થા
સ્તનપાન
Manilith 450 SR Tablet is to be taken with food.
None
None
CAUTION
It is unsafe to consume alcohol with Manilith 450 SR Tablet.
UNSAFE
Manilith 450 SR Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
CONSULT YOUR DOCTOR
Manilith 450 SR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
CONSULT YOUR DOCTOR
Manilith 450mg Tablet SR માટે સોલ્ટની માહિતી
Lithium carbonate(450mg)
Manilith tablet sr ઉપયોગ
{med_name} is used for mania and Bipolar disorder.
Manilith tablet sr કેવી રીતે કાર્ય કરે
Manilith 450 SR Tablet works by suppressing the abnormal and excessive activity of the nerve cells in the brain.
Manilith tablet sr ની સામાન્ય આડઅસરો
Tremors, Slurred speech, Uncoordinated body movements, Nausea, Acne, Increased white blood cell count, Memory impairment, Hair loss, Goiter (enlarged thyroid gland), Skin rash, Increased thirst, Weight gain, Polyuria, Diarrhea, Vomiting
Manilith Tablet SR માટે સબસ્ટિટ્યુટ
18 સબસ્ટિટ્યુટ
18 સબસ્ટિટ્યુટ
Sorted By
- Rs. 56.47pay 23% more per Tablet SR
- Rs. 60pay 30% more per Tablet SR
- Rs. 42.43save 8% more per Tablet SR
- Rs. 38.50save 16% more per Tablet SR
- Rs. 55pay 20% more per Tablet SR
Manilith Tablet SR માટે નિષ્ણાતની સલાહ
- Lithium carbonate is one of the most effective long-term treatment for bipolar disorder.
- It may also be used for the treatment of mania.
- Your lithium blood levels, thyroid function, and kidney function may be monitored as long as you take this medicine.
- It may cause diarrhea and dehydration. Drink plenty of water and and use normal amounts of salt. Inform your doctor if you start or stop a low-salt diet.
- Monitor your weight during treatment as Lithium carbonate can cause weight gain.
- Do not drive or do anything that requires mental focus until you know how it affects you.
- Inform your doctor if you have persistent stomach upset, problems with your speech, or extreme drowsiness. Your dose may need to be adjusted.
- Do not take Lithium carbonate if you are pregnant or breastfeeding.
- Do not stop taking the medication suddenly without talking to your doctor.
Manilith 450mg Tablet SR માટે વારંવાર પૂછાતાં પ્રશ્નો
Lithium carbonate
Q. How quickly does Manilith 450 SR Tablet work?
It takes some time before you see improvement in your symptoms after taking Manilith 450 SR Tablet. Though it varies from person to person, it may take 1-3 weeks or longer for you to see the full benefits of Manilith 450 SR Tablet. Do not stop taking Manilith 450 SR Tablet if you feel you are not improving. Instead, discuss it with your doctor.
Q. Does Manilith 450 SR Tablet make you sleepy?
Yes, Manilith 450 SR Tablet can cause nervous system disorders like sleepiness and dizziness and feeling confused. It can also cause rapid eye movements, blurred vision, or blind spots in your eyesight. If you experience any of these symptoms, consult your doctor. In addition, avoid driving or operating heavy machinery as it can be hazardous for you.
Q. Is Manilith 450 SR Tablet bad for kidneys?
Yes, Manilith 450 SR Tablet may cause kidney problems. Manilith 450 SR Tablet is not prescribed in patients who already have severe kidney impairment. The kidney problems may not be reversible and the symptoms include swollen ankles, passing a lot of urine and feeling thirsty. Before starting treatment with Manilith 450 SR Tablet, your doctor will get blood tests done to see if your kidney function is normal. During Manilith 450 SR Tablet therapy, any gradual or sudden changes in renal function, even within the normal range, may indicate the need for re-evaluation of treatment.